Stiolto Respimat

Olodaterol Hydrochloride,

Tiotropium Bromide Monohydrate

5.7 Moderate risk

Stiolto Respimat & Dyspnoea

17.6%

of users reported Dyspnoea

55.2%

also reported Hospitalization

61.8%

are women

Most common medical consequences

Hospitalization

55.2%

Severe reaction

27.6%

Death

10.3%

Life-threatening condition

6.9%

Have you experienced any negative side effects from this medication?

Stiolto Respimat: general information

Most common side effects (44)

Most commonly affected ages

50 - 59 years

6.2%

60 - 69 years

32.4%

70 - 79 years

40.1%

80 - 89 years

20.4%

90 - 99 years

0.9%

On this page